Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound

Eli Lilly and Walmart on Wednesday said they have teamed up to expand access to the drugmaker's weight loss drug Zepbound, allowing U.S. patients to get vials of the blockbuster injection at direct-to-consumer prices through retail locations for the first time. The announcement comes as Eli Lilly works to maintain its dominance over rival Novo Nordisk in the booming market for a class of obesity and diabetes drugs called GLP-1s. It also comes as the Trump administration pressures drugmakers to make it easie ...